Rejuvenation in Older Adults Receiving Oral Ghrelin

  1. Markus Gaugg, MD
  1. From Kaiser Franz Josef Hospital, 1100 Vienna, Austria.

    TO THE EDITOR:

    I read with interest the study by Nass and colleagues (1). I would like to address some critical issues, with particular reference to adverse events.

    First, growing evidence suggests that IGF-I is a cytokine involved in promotion and …

    « Previous | Next Article »Table of Contents